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INTRODUCTION 
 
A growing number of contemporary women choose to 
delay parenthood, making ovarian aging an increasingly 
important reproductive health issue. In the United Sates, 
the number of women delivering their first child after 
the age of 35 increased from 1/100 in 1970 to 1/10 in 
2016; the average age of first-time mothers increased 
from 21.4 to 26.6 during the same time period [1]. 
Within the context of infertility treatment, ovarian aging 
is often used to refer to the declining potential of 
ovaries to produce oocytes in adequate number or 
quality in response to controlled ovarian stimulation [2]. 
Patients who present with ovarian aging are commonly 
diagnosed with diminished ovarian reserve (DOR), and 
offered in vitro fertilization (IVF) using either their own 
eggs or donated eggs or embryos. The number of 
women undergoing IVF for DOR has been steadily 
increasing in the United States, where DOR accounted 
for 10% of assisted reproductive technology (ART) 
cycles in 2003, 14% in 2008, and 19% in 2015; the 
number of fresh IVF cycles using non-donor oocytes 
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ABSTRACT 
 
An algorithm assessing the methylation levels of 353 informative CpG sites in the human genome permits 
accurate prediction of the chronologic age of a subject. Interestingly, when there is discrepancy between the 
predicted age and chronologic age (age acceleration or “AgeAccel”), patients are at risk for morbidity and 
mortality.  Identification of infertile patients at risk for accelerated reproductive senescence may permit 
preventative action.  This study aimed to assess the accuracy of the “epigenetic clock” concept in reproductive 
age women undergoing fertility treatment by applying the age prediction algorithm in peripheral (white blood 
cells [WBCs]) and follicular somatic cells (cumulus cells [CCs]), and to identify whether women with premature 
reproductive aging (diminished ovarian reserve) were at risk of AgeAccel in their age prediction.  Results 
indicated that the epigenetic algorithm accurately predicts age when applied to WBCs but not to CCs. The age 
prediction of CCs was substantially younger than chronologic age regardless of the patient’s age or response to 
stimulation. In addition, telomeres of CCs were significantly longer than that of WBCs. Our findings suggest that 
CCs do not demonstrate changes in methylome-predicted age or telomere-length in association with increasing 
female age or ovarian response to stimulation. 
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performed for women with diminished ovarian reserve 
almost doubled reaching over 13,000 cycles during the 
same time period [3]. Similarly, the number of women 
undergoing oocyte donation increased from 11,627 in 
2003 to over 20,000 cycles in 2015 [3]. Despite the 
obvious significance of ovarian aging as a clinical 
entity, its pathophysiology remains poorly understood. 
 
Recent work has demonstrated that the methylation 
profile of a wide range of somatic tissues can be used to 
accurately predict the chronologic age of humans. This 
concept, termed the “epigenetic clock”, was developed 
from a large dataset of methylation levels of >7,800 
human tissue specimens from multiple longitudinal 
studies across various fields of medicine (such as the 
Women’s Health Initiative [WHI] and the Framingham 
Heart Study [FHS]) [4]. The predictive model was 
generated by performing an elastic net regression of 
methylation levels of thousands of CpG sites to 
determine which sites were most predictive of the age 
of the subject from which the DNA was derived.  
Published in 2013, Horvath described that the 
chronologic age of a subject could be predicted to 
within a median accuracy of 43 months by utilizing an 
algorithm derived from the 353 most predictive CpG 
sites across the genome. 
 
This discovery was novel for multiple reasons. First, 
this was the first robust report demonstrating that the 
epigenome changes in a predictable pattern with age, a 
discovery that has widespread implications in the aging 
research. Second, the model was remarkably accurate in 
predicting chronological age across multiple different 
tissue types. Thus, if Horvath’s algorithm was applied 
to a white blood cell (WBC) that was only two days old, 
it was still capable of predicting whether it was derived 
from a 45-year-old or a 75-year-old patient with 
remarkable accuracy. The same algorithm could be used 
to predict the age of the same subject from a buccal 
swab or liver biopsy [5]. Likewise, additional factors 
such as risk for diseases or phenotypic trades have been 
recently incorporated into these algorithms so as to 
increase accuracy and clinical relevance [6].   
 
Perhaps the most intriguing line of research that has 
resulted from this work, is evidence from multiple 
studies that subjects with a discrepancy between their 
epigenetic   clock    age   prediction    and   their   actual 
Table 1. Patient and cycle characteristics for study participants in younger reproductive age group. 
 
 Group A 
(young good responders) 
Group B 
(young poor responders) 
P value 
n 20 20 - 
Age (y) 32.3 (+/- 2.1) 33.2 (+/- 2.2) 0.16a 
BMI (kg/m2) 25.6 (+/- 4.5) 26.5 (+/- 4.8) 0.56a 
AMH 5.7 
(3 – 12.6) 
0.85  
(0.3 – 2.2) 
<0.001b 
E2 on day of trigger 4903  
(1972 - 7032) 
1319.0  
(669 – 2663) 
<0.001b 
No. of mature follicles (>15mm) 18  
(15 – 32) 
4  
(3 – 5)  
<0.001b 
No. of metaphase II oocytes 17 
(11 – 33) 
4 
(1 – 11) 
<0.001b 
No. of 2PN 15 
(0 – 27) 
3 
(0 – 11) 
<0.001b 
No. of clinically usable 
blastocysts 
7 
(0 – 20) 
2 
(0 – 5) 
<0.001b 
a Student’s t-test 
b Mann-Whitney U test 
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chronologic age appear to be at increased risk of 
morbidity. Data from a meta-analysis of multiple 
longitudinal cohort studies (including the WHI and 
FHS) suggest that patients with evidence of an 
accelerated epigenetic clock (AgeAccel; age prediction 
older than actual chronologic age) were at increased risk 
for all-cause mortality over subjects in which the 
algorithm accurately predicted age [7, 8].  Among WHI 
patients in the study, AgeAccel of >10 years was 
associated with a 48% increased risk of death per 
annum [9].   
 
These findings may have relevance to the study of 
female reproduction. Many infertile women 
demonstrate evidence of diminished ovarian reserve 
(DOR) or poor response to controlled ovarian 
stimulation (COS) consistent with accelerated follicular 
depletion, a finding associated with reproductive aging 
[10, 11]. Interestingly, evaluation of the methylation 
profile of WBC, saliva, and buccal swabs of 
postmenopausal women demonstrate that earlier 
menopause is associated with AgeAccel in Horvath’s 
model [12]. However, because all samples were 
evaluated from postmenopausal women, it is unclear 
whether it is menopause that changes the methylation 
profile or if patients with AgeAccel prior to menopause 
could be predicted to exhibit premature reproductive 
aging. Furthermore, while the epigenetic clock has been 
evaluated in multiple reproductive tissues 
(endometrium, spermatozoa), it has not been tested in 
the cells most responsible for the decline ovarian steroid 
production associated with reproductive aging – 
follicular cells.   
 
Telomere length (TL) is a known biomarker for 
biological aging and has been associated with the 
female reproductive lifespan [13, 14]. Moreover, TL in 
WBCs has also been correlated with extrinsic epigenetic 
age acceleration (EEAA), a measure of DNA 
methylation derived from Horvath’s algorithm [15]. 
Therefore, it could be hypothesized that the relative 
amount of telomere DNA in follicular and white blood 
cells might as well differ in reproductive age women 
according to their age and ovarian response to 
stimulation. Indeed, a recent study reported that 
granulosa cells in patients with biochemical primary 
Table 2. Patient and cycle characteristics for study participants in older reproductive age group.  
 Group C 
(older physiologic poor 
responders) 
Group D 
(older unexpected good 
responders) 
P value 
n 20* 17  
Age (y) 41.9 (+/- 1.5) 41.8 (+/- 1.3) 0.86a 
BMI (kg/m2) 27.9 (+/- 5.5) 24.3 (+/- 4.9) 0.046a 
AMH 0.72 
(0.13 – 1.2)  
3.93  
(1.8 – 17) 
<0.001b 
E2 on day of trigger 1096  
(570 – 2501) 
4222  
(1655 – 6532) 
<0.001b 
No. of mature follicles 
(>15mm) 
4 
(1 – 5) 
15 
(11 – 27) 
<0.001b 
No. of metaphase II oocytes 3 
(0 – 9) 
13 
(8 – 30) 
<0.001b 
No. of 2PN 3 
(0 – 7) 
11 
(4 – 25) 
<0.001b 
No. of clinically usable 
blastocysts 
1 
(0 – 3) 
4 
(0 – 15) 
<0.001b 
*Two patients had no oocytes retrieved at time of oocyte retrieval 
a Student’s t-test 
b Mann-Whitney U test 
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ovarian insufficiency (POI) possess significantly shorter 
telomeres than healthy controls, as was also the case for 
TL in leukocytes [16]. 
 
In the current study, we sought to evaluate 1) whether 
the epigenetic clock model of aging applied to 
reproductive age women accurately predicts 
chronologic age in peripheral somatic cells (WBCs) and 
follicular somatic cells (cumulus cells [CC]); 2) whether 
the age predicted by DNA methylation of these sites in 
WBCs or CCs changes in women with phenotypic 
evidence of altered progression of reproductive aging in 
the form of poor or unexpected good response to COS; 
and 3) whether the relative telomere length of CCs or 
WBCs is associated with patient’s age or response to 
hyperstimulation.  
 
RESULTS 
 
Patient characteristics 
 
A total of 77 women were enrolled in the study (Groups 
A (young good responders; n=20), B (young poor 
responders; n=20), and C (older physiologic poor 
responders; n=20), and D (older unexpected good 
responders; n=17). Patient and cycle specific descriptive 
statistics for the younger groups (A and B) are provided 
in Table 1. Group B patients had lower anti-Müllerian 
hormone (AMH, a marker of ovarian reserve) and 
estradiol (E2) levels on day of trigger compared to 
group A. They also had fewer mature oocytes retrieved, 
fertilized oocytes at two pronuclei (2PN) stage, and 
clinically usable blastocysts. Descriptive statistics for 
the older reproductive age groups are provided in Table 
2. While there was no difference in age, group C 
patients (older physiologic poor responders) had a 
greater body mass index (BMI) than Group D patients. 
Otherwise, the group C (older physiologic poor 
responders) had lower AMH and E2 levels, and fewer 
mature oocytes, 2PNs and blastocysts, compared to 
group D. Of note, two patients in Group C had no 
oocytes recovered at time of retrieval and thus CC 
methylation or telomere length analysis could not be 
performed. 
 
Evaluation of methylation-based age prediction 
using the Horvath model in WBCs and CCs of 
reproductive-age women 
 
The results of the age prediction analysis performed in 
WBCs and CCs, using the algorithm described by 
Horvath are depicted in Figure 1. Of note, three 
cumulus samples (two from group B and one from 
group C) were excluded from the analysis due to failure 
to pass QC standards. The age predicted by the 353 
CpG site algorithm was consistent with the patient’s 
chronologic age in WBC samples (Figure 1). However, 
the overall DNA methylation level was significantly 
lower in CC samples compared to WBC samples from 
the same patient (p < 0.001). The predicted age in CCs 
was also substantially younger (Figure 1). The predicted 
age was unchanged whether the CC DNA was derived 
from patients in the younger age groups (groups A and 
B) or the older age groups (groups C and D); the 
predicted age was similar with an average age of 9.3 
years old. 
 
Evaluation of whether ovarian response category 
alters methylation-based age prediction 
 
When using a linear model that included age as a 
covariate, there was no association between the ovarian 
response category and age prediction of WBC 
methylation using the Horvath model on ANOVA (p = 
0.12) (Figure 1). There was also no evidence of 
difference in the distribution of predicted ages when 
using CC-derived methylation levels on Wilcoxon rank 
sum (p = 0.36) (Figure 1). In other words, age 
prediction in CCs was not significantly altered 
according to the response category within age groups. 
However, it is notable that in 77.5% (31/40) of patients 
in Groups A and B, the WBC age prediction was older 
than true chronologic age. This was true in 85% (17/20) 
of Group B (young poor responders).   
 
 
Figure 1. 353 CpG “epigenetic clock” age prediction in 
white blood cells and cumulus cells. Black line indicates a 
perfect prediction of chronological age (y=x). Study groups are 
indicated with colors: Red A= <35 years old and good 
responder (≥15 mature follicles), green B= <35 years old and 
poor responder (≤5 mature follicles), blue C= >40 years old and 
poor responder (≤4 mature follicles) and magenta D= >40 
years old and good responder (≥12 mature follicles). Tissue 
types are indicated by symbols.  
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Relative telomere length measurements in WBCs 
and CCs of reproductive-age women 
 
Average relative TL was successfully measured in all 
WBC samples (77). However, genomic DNA from CCs 
was available for TL measurements in only 63 subjects 
after CC methylation assessment. Relative TL did not 
differ among the four study groups in both WBCs and 
CCs, and was therefore found not to be associated with 
patient’s age or ovarian response after stimulation 
(p=0.329; WBC F(3,73)= 0.9, p=0.4462) (Supplemental 
Figures 1 & 2). On the other hand, when comparing TL 
between tissues, CCs presented significantly longer 
telomeres than WBCs irrespective of the study group 
(p<0.0001, Figure 2). In addition, a paired analysis, 
which included only subjects with DNA available from 
both CCs and WBCs for TL measurements (59 subjects) 
also revealed that telomeres are significantly longer in 
CCs than in WBCs by an average of 2.16-fold change 
(p<0.0001, Supplemental Figure 3).  
 
DISCUSSION 
 
These data demonstrate that an age prediction model 
according to the methylation level of 353 CpG sites in 
DNA derived from WBCs accurately predicts the 
chronologic age of reproductive age women pursuing 
assisted reproduction. However, the methylation profile 
of CCs does not provide an accurate age prediction 
according to the same model. Indeed, the algorithm’s 
age prediction was consistently younger in CCs 
regardless of the age of the subject, a finding that was in 
agreement with TL measurements, where CCs 
presented in average longer telomeres than WBCs. 
Furthermore, categorization of patients according to 
ovarian response did not appreciably change the age 
prediction in WBCs or CCs, neither was it associated 
with relative telomere DNA length. 
 
This is the first prospective assessment of the 
“epigenetic clock” model of aging in women of 
reproductive age pursuing fertility treatment. While 
many reports across multiple medical disciplines have 
illustrated the accuracy of Horvath’s model for 
predicting chronologic age [17-19], and the association 
between accelerated epigenetic age (AgeAccel) and 
morbidity and mortality [7-9], reproductive medicine 
may provide a unique lens with which to evaluate 
usefulness of an epigenetic clock as a marker of general 
health and wellbeing. Indeed, reproductive longevity 
has been reported to correlate with overall longevity 
[20]. While establishing a robust model in this 
population will require significantly greater number of 
samples, further study could help illustrate whether the 
accelerated epigenetic profile described in women with 
earlier menopause [12] may already be evident during 
the reproductive years. If so, this information would be 
valuable for many reasons. Patients at risk for earlier 
menopause could benefit from lifestyle and medical 
interventions during their reproductive years to optimize 
cardiovascular and bone health as they face earlier 
cessation of ovarian steroid production. Furthermore, 
 
Figure 2. Cumulus cells have longer telomeres than white blood cells. Comparison of average relative telomere length of all 
study subjects indicates that ovarian cells present longer telomeres than white blood cells (t(138)=-14.46, p<0.0001). Tissues are 
indicated with symbols. Study groups are indicated with colors. A= <35 years old and good responder (≥15 mature follicles), B= <35 
years old and poor responder (≤5 mature follicles), C= >40 years old and poor responder (≤4 mature follicles) and D= >40 years old 
and good responder (≥12 mature follicles). Average relative TL is reported as Average dCT values, which are inversely proportional to 
actual TL. Therefore, higher average dCTs indicate shorter telomeres.  
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given that fertility declines long before perturbations in 
the menstrual cycle are evident, patients at risk of 
premature reproductive aging could take measures to 
ensure their family building plans are addressed in a 
timely fashion.  
 
With the premise that a poor response to stimulation 
may represent the manifestation of premature 
reproductive aging in mind, we attempted to study 
whether patients with diminished ovarian reserve 
exhibited a methylation profile consistent with 
accelerated aging in somatic cells which had previously 
been demonstrated to fit the algorithm – WBCs. While 
there was no clear association evident, our classification 
strategy may have been insufficient to highlight subtle 
differences according to response phenotype. It is also 
possible that infertile patients in general (even those 
with evidence of a normal ovarian response) may 
demonstrate alterations in their epigenetic profile, such 
that the age prediction overlapped between groups. 
Indeed, while the age prediction model was accurate in 
WBCs within the margin of error difference observed in 
prior studies of the epigenetic clock (a median error of 
3.6 years) [4], the majority of patients in the younger 
age group demonstrated an age prediction that was 
higher than their actual chronologic age, and this was 
more prominent in young poor responders. While this 
could represent an assay related or analytical artifact, 
future studies would be well served to use fertile 
controls and study whether infertility patients in general 
exhibit any evidence of accelerated aging according to 
the epigenetic clock model. While large numbers would 
be needed, this study design would help elucidate 
whether this model provides any predictive value for 
helping identify patients at risk for subfertility. 
 
The ineffectiveness of the model when applied to CCs 
also raises interesting questions. While the epigenetic 
clock is accurate across many different tissue types, 
there are some tissues that do not produce the same 
predictable changes in methylation levels. In addition to 
CCs, breast and endometrial cells also do not fit the 
Horvath algorithm. It is possible that there may be a 
unifying mechanism responsible for explaining why 
these tissues – all of which respond to the cyclic 
hormonal changes of the menstrual cycle – do not 
exhibit the same epigenetic pattern of aging. Notably, 
unlike CCs, breast and endometrial tissues exhibit older 
than expected age predictions according to the 
epigenetic clock [4, 21]. It is possible that different CpG 
sites may be altered in a predictable manner in these 
hormone responsive tissues. These sites may also be 
altered in infertile patients. Indeed, dysregulated 
epigenetic profiles have been described in women with 
endometriosis [22, 23].   
Alternatively, the young age prediction in CCs, 
consistent with young predictions seen in stem cells, 
could be the result of the communication between 
oocytes and CCs through gap junctions [24]. Indeed, 
oocyte-specific factors play key roles in 
granulosa/cumulus cell function, and targeted deletion 
of oocyte-specific genes may result in aberrant cumulus 
function associated with loss of gap junctions and 
transzonal processes [25-27]. Importantly, TL 
measurements were in agreement with the 
aforementioned results of no correlation of the 
epigenetic clock with ovarian response to 
hyperstimulation, and with the younger age prediction 
in CC compared to WBCs, since the former tissue type 
presented longer telomeres by an average fold change of 
2.16. Attrition of telomeres has been extensively 
established to be correlated with cell aging, and was 
recently reported to be enhanced in follicular cells of 
patients with primary ovarian insufficiency [14, 16]. 
Although the telomere theory of reproductive aging has 
mostly focused on the effect of shorter telomeres on 
meiotic disruption and higher risk of aneuploidies [28, 
29], it is also possible that the length of telomeres in 
follicular cells might play a role in oocyte maturation 
and the entire ovarian environment. As stated above, 
engagement in communication with the oocyte might 
regulate programmed aging by both epigenetic changes 
and telomere remodeling in these cells, in contrast to 
other peripheral tissues. At the same time, the expected 
correlation between subject’s age and telomere length 
was not found in either tissue type, probably because of 
a limited sensitivity of the TL assay to differentiate 
subtle changes in TL between patients.  
 
Our findings demonstrate that an aging algorithm 
developed based on somatic cell methylome analysis 
fails to predict CC senescence or ovarian response to 
stimulation. While, this finding could be due to 
alternative methylation of CpG sites in CCs, longer TL 
observed in CCs compared to WBCs suggests a younger 
phenotype, possibly due to a continuing bidirectional 
communication with the oocyte. Further studies are 
needed to establish whether oocyte-CC communication 
affects age-related sites in the methylome, and whether 
an algorithm can be developed using alternative CpG 
sites in CCs that would predict patient age and/or 
ovarian response to stimulation. 
 
MATERIALS AND METHODS 
 
Design 
 
All patients were recruited under Institutional Review 
Board approval during in vitro fertilization (IVF) cycles 
at Reproductive Medicine Associates of New Jersey 
(Basking Ridge, NJ) between February and July 2017. 
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Each IVF cycle was managed by the patient’s physician 
per typical clinic protocol. Doses of gonadotropins and 
protocols were selected according to results of the 
patient’s precycle, ovarian reserve testing by anti-
Müllerian hormone (AMH) and antral follicle count. 
Stimulation was achieved with injectable medications 
with follicle stimulating hormone (FSH) (recombinant 
or urinary) and luteinizing hormone (LH) activity 
(human menopausal gonadotropin or low dose human 
chorionic gonadotropin). Prevention of a premature LH 
surge prior to oocyte retrieval was achieved with either 
a gonadotropin releasing hormone (GnRH) antagonist 
on day 8 of the menstrual cycle or via pituitary 
downregulation with GnRH agonist. Doses of 
gonadotropins were adjusted according to response to 
stimulation (as determined by serial sonographic 
assessments of follicle growth and estradiol levels). The 
timing of administration of human chorionic 
gonadotropin or GnRH agonist trigger for final oocyte 
maturation occurred when the patient’s primary 
physician determined that a maximum number of 
follicles had reached the ideal size for retrieval of a 
mature oocyte (between 15 and 22mm in diameter).  In 
general, this occurred when at least 2 follicles measured 
18mm in diameter. Oocyte retrieval was performed 36 
hours after administration of the trigger shot. 
 
Recruitment occurred on day of trigger injection for 
final oocyte maturation. In order to analyze whether 
ovarian response to stimulation was associated with 
alterations in the epigenetic profile, four categories of 
patients were recruited. Group A consisted of women 
<35 years old with >14 mature follicles (at least 15mm 
on transvaginal ultrasound) (young good responders).  
A threshold of >14 mature follicles was selected as this 
represented the top tertile of patients in this age group in 
this clinic according to internal data.  Group B consisted 
of women <35 years old with <5 mature follicles (at 
least 15mm) on day of trigger (young poor responders). 
A threshold of <5 mature follicles was selected as this 
represented the bottom 15th percentile of patients in this 
age group according to internal data. Group C consisted 
of women >40 years old with <5 mature follicles (old 
physiologic poor responders) (bottom tertile). Group D 
consisted of women >40 years old with >12 follicles 
(old unexpected good responders) (top 15th percentile).   
 
On the day of oocyte retrieval, enrolled patients had a 
tube of peripheral blood drawn for evaluation of WBC 
methylation analysis. At time of oocyte retrieval, the 
follicular fluid of each enrolled patient was evaluated in 
a Falcon 1029 dish for evidence of cumulus oocyte 
complexes (COCs) per standard clinical routine. 
Identified COCs were isolated from cellular debris and 
blood and placed in a separate Falcon 1007 dish for 
washing. After all COCs were placed in the wash dish, 
they were passed in and out of a sterile, fire polished, 
glass Pasteur pipette three times to remove any debris 
that accompanied COCs into the wash dish. Cleaned 
COCs were then placed in a separate Falcon 1007 and 
excess cumulus cells were mechanically dissected from 
cumulus oocyte complexes with 27g needles. Oocytes 
were then moved to an organ well dish for continued 
culture, and the cut cumulus cells were pooled together 
for DNA isolation. 
 
Methylation analysis 
 
Isolation of WBC DNA from peripheral blood samples 
was performed using the QIAsymphony kit (Qiagen, 
Redwood City, CA, USA). CCs DNA was purified 
using DNeasy blood and tissue kit (Qiagen, Redwood 
City, CA, USA). Bisulfite conversion was then 
performed using the Zymo EZ DNA methylation kit 
(Zymo Research, Irvine, CA, USA). The Illumina 850K 
DNA methylation EPIC array (San Diego, CA) was 
then utilized to measure DNA methylation levels 
throughout the genome [30, 31].  
 
Methylome data analysis: evaluation of Horvath age 
prediction in reproductive-age women 
 
To evaluate the age prediction by the Horvath 
algorithm, beta values were calculated using the 
intensities of methylated and unmethylated signals for 
each of the 353 informative CpG sites described by 
Horvath [4]. This analysis was performed separately for 
the WBC samples and the cumulus samples.   
 
Methylome data analysis: evaluation of whether 
ovarian response category alters age prediction 
 
A linear model with female age as a covariate was used 
to evaluate the relationship between the ovarian 
response group and the age predicted by the Horvath 
algorithm with ANOVA. A Wilcoxon rank sum test was 
carried out for evaluating whether samples from poor 
response and normal response groups had the same 
distribution (Figure 2). 
 
Data analysis was carried out with R version 3.4.0 (R 
Development core 2008). Beta value calculations, 
background correction and normalization by ssNoob 
[32], and data quality control were carried out with the 
minfy R package (version 1.24.0) [33]. A total of 18 
control samples were included in the methylation 
analysis to assess for data normalization. Data quality 
control (QC) was also performed by inspecting intensity 
metrics and raw beta distributions.  
www.aging-us.com 3768 AGING 
Relative Telomere Length Measurements 
 
Relative TL was measured as previously described [29, 
34] by means of quantitative real-time PCR using 
isolated genomic DNA from both WBCs and CCs as 
starting material. PowerUp SYBR green Master Mix 
was used as detector (Applied Biosystems). qPCR 
quantification was performed in a 7900HT fast real time 
PCR system (Thermofisher Scientific). A Taqman 
Custom gene expression assay for the multicopy gene 
Alu (Assay ID: APPRKX3, Thermofisher Scientific) 
was used as endogenous control for normalization of TL 
measurements for each patient.  
 
Four technical replicates for each subject and tissue type 
were established. Cycle threshold (Ct) values of the Tel 
assay (PCR reaction of telc and telg primers) and Alu 
assay were subtracted for each sample. Next, an average 
delta Ct (dCt) value was generated for each patient from 
all four technical replicates. Therefore, Ct values are 
inversely proportional to actual TL, where lower values 
indicate longer telomeres. 
 
Statistical tests (Student’s t-test and ANOVA) for 
analysis of relative telomere length measurements were 
performed with the Analyse-it software for Microsoft 
Excel (version 2.20). 
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SUPPLEMENTARY MATERIAL 
  
 
 
Supplemental Figure 1. Relative telomere length in cumulus cells is not associated with subject’s age or ovarian 
response after controlled ovarian hyperstimulation. Distribution of average relative telomere length measurements among 
study groups (ANOVA: F(3,59)= 1.17, p=0.329). A= <35 years old and good responder (≥15 mature follicles), B= <35 years old and poor 
responder (≤5 mature follicles), C= >40 years old and poor responder (≤4 mature follicles) and D= >40 years old and good responder 
(≥12 mature follicles). Blue lines indicate mean values. Black lines indicate median. Average relative TL is reported as Average dCT 
values, which are inversely proportional to actual TL. Therefore higher average dCTs indicate shorter telomeres.  
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Supplemental Figure 2. Relative telomere length in white blood cells is not associated with subject’s age or ovarian 
response after hyperstimulation. Distribution of average relative telomere length measurements among study groups (ANOVA: 
F(3,73)= 0.9, p=0.4462). A= <35 years old and good responder (≥15 mature follicles), B= <35 years old and poor responder (≤5 mature 
follicles), C= >40 years old and poor responder (≤4 mature follicles) and D= >40 years old and good responder (≥12 mature follicles). 
Blue lines indicate mean values. Black lines indicate median. Average relative TL is reported as Average dCT values, which are 
inversely proportional to actual TL. Therefore higher average dCTs indicate shorter telomeres. 
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Supplemental Figure 3. Telomeres are significantly longer in cumulus cells than in white blood cells by an average 
2.16-fold change. WBC: white blood cells, CC: cumulus cells. Paired analysis of average relative telomere length measurements in 
cumulus cells and leukocytes of 59 subjects with TL data of both tissues. WBC’s TL was used as reference to calculate the fold change 
difference (Paired-t(116)= -14.05, p<0.0001) .   
 
